The tide has turned against the AstraZeneca vaccine in Denmark and Norway and fewer available vaccine doses could delay the rollouts in the Nordics, potentially by several months. At this stage, we see nothing to change our view that the Norges Bank will be the first advanced central bank to start raising rates, later this year. However, the recent developments mean that the start of hikes could be delayed a bit, from late-summer as we currently assume, possibly into Q4.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services